Moreover, the positive correlation between TRPC1 expression and cancer progression provides a therapeutic window of opportunity; TRPC1 expression can be leveraged with magnetic field treatment in combination with DOX administration to achieve greater anti-tumor outcomes. The gene discussed is TRPC1; the disease is neoplasm.